Sen. Tina Smith sells $100K–$250K of Dexcom Inc (DXCM) while on a related committee
Sen. Tina Smith (D-MN) reported a sale of DXCM worth $100K–$250K.
Sen. Tina Smith (D-MN) reported that their spouse sold Dexcom Inc (DXCM) stock worth $100K–$250K on May 7, 2026. The trade was disclosed in a Periodic Transaction Report filed on May 10, 2026, 3 days after the trade.
Smith sits on the Senate Committee on Finance, whose work touches health care, an area that matters to Dexcom Inc.
In the year before, Smith reported 1 other trade in DXCM: 0 purchases and 1 sale.
Across all their reports we have read, Tina Smith disclosed 10 stock trades.
The law gives only a range for each trade, so the exact amount and price are not public.
What happened next: since the week of the sale, DXCM has risen 55.2%. A fall after a sale means the sale came before a drop.
Source: Periodic Transaction Report ↗. Written automatically from the report and weekly price data. Information, not investment advice. Published free for the public; congressional disclosure reports may not be used for commercial purposes or soliciting money.
Examples
In 2020 several senators faced questions over stock sales made after private briefings on the coronavirus. Those trades became public through the same kind of report this story is built from.
Explain it like I'm 13
Members of Congress write the rules for many companies, so the law makes them tell the public when they buy or sell stocks. This report is like a referee saying which team's merchandise they bought: it does not mean they did anything wrong, but it lets everyone check.